MOA of Fenofibrate:
Blocks nrlp3 inflammasomes. Nrf2 modulating antioxidant defense increases Beta hydroxybutyrate. Significantly affected cell cycle progression and pathways involved in cancer, including the mTOR signaling pathway and insulin signaling pathway. Destabilizes the viral receptor binding domain clears lung alveolar fatty debris induced by the viral inflammatory process.